MarketScreener Homepage > Equities > Deutsche Boerse AG > Canntab Therapeutics Limited TBF1 CA1377991023

Report

Delayed Deutsche Boerse AG - 01/22 02:04:09 am
0.492	EUR		+3.80%

2020

Canntab Announces Closing of Convertible Debenture Private Placement

2020

CANNTAB THERAPEUTICS : Begins Delivery of Tablets to MediPharm

2020

Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus

News

Most relevant

Official Publications

Sector news

Most relevant news about CANNTAB THERAPEUTICS LIMITED

2020	Canntab Announces Closing of Convertible Debenture Private Placement	NE
2020	CANNTAB THERAPEUTICS : Begins Delivery of Tablets to MediPharm	PR
2020	Canntab Therapeutics Announces End of Supply and Distribution Agreements with..	NE
2020	CANN GLOBAL : Canntab to Launch in Australia and Participate in Australia's Larg..	AQ
2020	CANNTAB THERAPEUTICS : to Launch in Australia and Participate in Australia's Lar..	PR
2020	Canntab Announces Closing of Purchases of Cannabis Processing Equipment and L..	NE
2020	CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL	AQ
2020	CANNTAB THERAPEUTICS : Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tab..	AQ
2020	CANNTAB THERAPEUTICS : Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tab..	PR
2020	CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL	AQ
2020	CANNTAB THERAPEUTICS : announces planned purchases of cannabis processing equipm..	AQ
2020	CANNTAB THERAPEUTICS : Appoints Larry Latowsky as CEO	AQ
2020	CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL	AQ
2020	CANNTAB THERAPEUTICS : and Medipharm Labs Enter Into a Wholesale Tablet Purchase..	AQ
2020	CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL	AQ
2020	CANNTAB THERAPEUTICS : Appoints Joshi Laxminarayan as Chief Scientific Officer	AQ
2020	CANNTAB THERAPEUTICS : to Present at the Canaccord Genuity 2020 Virtual Cannabis..	AQ
2020	CANNTAB THERAPEUTICS : Closes Final Tranche of Private Placement for Aggregate P..	AQ
2020	CANNTAB THERAPEUTICS : Announces Replacement of Advisor Warrants and Intention t..	AQ
2020	Canntab Announces Cancellation of Options and Issuance of Warrants	NE
2020	CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL	AQ
2020	CANNTAB THERAPEUTICS : Receives Health Canada Licence and Closes $3.08M Offering	AQ
2020	CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL	AQ
2020	CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL	AQ
2020	CANNTAB THERAPEUTICS : Awarded Health Canada Cannabis Research Licence	AQ
2020	CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL	AQ
2020	CANNTAB THERAPEUTICS : Announces Non-Brokered Private Placement	AQ
2019	CANNTAB THERAPEUTICS : Submits Site Evidence Package to Health Canada to Obtain ..	AQ
2019	CANN GLOBAL LIMITED (ASX : CGB) Operational Update	AQ
2019	CANNTAB ACHIEVES KEY MILESTONE : Canntab Enters Into Supply & Distribution Agree..	PR
2019	CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL	AQ
2019	CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL	AQ
2019	InvestmentPitch Media Video Discusses Canntab's Receipt of Initial Indication..	NE
2019	InvestmentPitch Media Video Discusses Canntab's Update of Significant Develop..	NE
2019	CANNTAB THERAPEUTICS : provides corporate update	PR
2019	InvestmentPitch Media Video Discusses Canntab's Term Sheet with Heritage Cann..	NE
2019	InvestmentPitch Media Video Discusses Canntab Approaching Revenue under FSD P..	NE
2018	InvestmentPitch Media Video Discusses Canntab Therapeutics and its Applicatio..	NE
2018	Canntab Files Application to Become Licensed Producer	NE
2018	InvestmentPitch Media Video Discusses Canntab Therapeutics LOI With NewCanna ..	NE
2018	Canntab Enters LOI for Bi-Lateral Sales & Distribution and Cannabis Oil Suppl..	NE
2018	CANNTAB THERAPEUTICS : Enters LOI for Bi-Lateral Sales & Distribution and Cannab..	EQ
2018	FSD Pharma Receives First Delivery of Canntab Equipment with a Capacity to Ma..	NE
2018	Canntab Added to CSE Composite Index	NE
2018	Canntab Sets New All-Time High Trading Prices and Volume	NE
2018	Canntab Exceeds All-Time High Trading Prices and Grants Options	NE
2018	Canntab Signs Collaboration and Profit Sharing Agreement with FSD Pharma for ..	NE
2018	CANNTAB AND EMBLEM ANNOUNCE POSITIVE : Proceeding to Clinical Trials	NE
2018	Canntab Therapeutics Launches Capital Markets Communications Strategy	NE
2018	InvestmentPitch Media Video Discusses Canntab Therapeutics LOI with FSD Pharm..	NE
2018	Canntab Announces Launch of Innovative Hemp Oil Capsules	NE
2018	Canntab Announces Director Resignation	NE
2018	Canntab Therapeutics Files 2 New Canadian Patent Applications Related to Phar..	NE
2018	CANNTAB THERAPEUTICS : Appoints Bob Woloschuk to Advisory Board	EQ
2018	Canntab Appoints Bob Woloschuk to Advisory Board	NE
2018	Canntab Provides Clarification on CFN Media Engagement	NE
2018	CSE New Listing - Canntab Therapeutics Commences Trading on the Canadian Sec..	NE
2018	Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical C..	NE
2018	Canntab Provides Corporate Update	NE

Upcoming sector events

01/26/21	JOHNSON & JOHNSON : Jahr 2020 Ergebnisveröffentlichung
01/26/21	NOVARTIS AG : Jahr 2020 Ergebnisveröffentlichung
01/28/21	LUPIN LIMITED : Q3 2021 Ergebnisveröffentlichung
01/28/21	SUMITOMO DAINIPPON PHARMA CO., LTD. : Q3 2020 Ergebnisveröffentlichung

More events

Sector

Healthcare
	Pharmaceuticals & Medical Research
		Pharmaceuticals
			Pharmaceuticals
				Alternative Medicine